Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

UK to improve commercial viability of antibiotic research

Government unveils new research incentives as part of antimicrobial resistance strategy

Bristol-Myers Squibb (BMS) building

BMS says it defends Sprycel patent in India

Blocks attempts to issue compulsory license for leukaemia drug

- PMLiVE

Baxter’s Nick Roger joins Bedrock

Takes up role as strategic solutions director at med comms agency

- PMLiVE

AZ licenses Merck ovarian cancer drug

Pays $50m upfront for MK-1775

Richard Ranieri leaves Dendreon for Biomarin

Will head human resources and corporate affairs

Pharma deals during August 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for August 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

EU flag

First biosimilar mAb gets the nod in EU

Approval for Hospira's version of J&J's Remicade has global implications

Biogen Idec building

Biogen Idec to develop Parkinson’s drugs with Amicus

Companies will develop treatments to target genetic mutation

- PMLiVE

FDA guidance clears path for Advair generics

Offers simplified process for potential copies of GSK’s asthma and COPD drug

- PMLiVE

AZ sponsors heart attack risk app

GRACE 2.0 app aims to help HCPs decide on the most appropriate treatments

- PMLiVE

Interlace realigns business to focus on communications

Sells off regulatory and pharmacovigilance interests

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links